Prados, M., Cloughesy, T., Samant, M., Fang, L., Wen, P. Y., Mikkelsen, T., . . . Friedman, H. S. (2011). Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Oxford University Press.
Dyfyniad Arddull ChicagoPrados, Michael, et al. Response As a Predictor of Survival in Patients With Recurrent Glioblastoma Treated With Bevacizumab. Oxford University Press, 2011.
Dyfyniad MLAPrados, Michael, et al. Response As a Predictor of Survival in Patients With Recurrent Glioblastoma Treated With Bevacizumab. Oxford University Press, 2011.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.